Nachrichten zur Bristol-Myers Squibb Co Aktie

Price target on Bristol-Myers stock cut to $51 at UBS

Analysts at UBS cut their price target on shares of Bristol-Myers Squibb Co. on Thursday to $51 from $55…

Zacks.com featured highlights include: CDW, Bristol-Myers, Celgene, PepsiCo and Northrop

Zacks.com featured highlights include: CDW, Bristol-Myers, Celgene, PepsiCo and Northrop...…

Bristol-Myers Squibb (BMY) is a Top Dividend Stock Right Now: Should You Buy-

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca

The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca...…

Bristol-Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know

Bristol-Myers Squibb (BMY) closed at $46.15 in the latest trading session, marking a -1.03% move from the prior day....…

Merger uncertainty and impending trials for Bristol-Myers leave investors in limbo

Investors are taking a wait-and-see approach to Bristol-Myers Squibb Co., according to Credit Suisse....…

Investors Playing ‘Wait and See’ on Changes at Bristol-Myers

Credit Suisse analyst Vamil Divan says investors see an upside in the company’s merger with Celgene, but as yet have…

Bristol-Myers Squibb And AbbVie: Pharma Dividend Opportunities With Large Margins Of Safety

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Stock Moves -1.11%: What You Should Know

In the latest trading session, Bristol-Myers Squibb (BMY) closed at $45.37, marking a -1.11% move from the previous day....…

Why Is Bristol-Myers (BMY) Up 2.6% Since Last Earnings Report-

Bristol-Myers (BMY) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Final trades: Bristol-Myers, Boeing, Copart, Gilead & Kratos Defense

The "Halftime Report" traders give their top stocks to watch for the second half....…

Mercks Keytruda Vs. Bristol-Myers Squibbs Opdivo In Q1 And Beyond

Two big pharma titans are battling for supremacy in the field of oncology immunotherapy. read more...…

Bristol-Myers Squibb: Share Repurchases No Benefit To Shareholders

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

As Bristol-Myers Continues to Slump, a Director Is Buying Up Shares

Ted Samuels paid $236,440 for 5,000 shares last week. It’s the first open-market purchase of Bristol-Myers stock by an insider…

Argus Questions Logic Behind Bristol-Myers Proposed Celgene Buy, Steps To Sidelines

Bristol-Myers Squibb Co (NYSE: BMY)s quest to expand its oncology franchise through its proposed acquisition of Celgene Corporation…

Top Analyst Upgrades and Downgrades: Alibaba, Baidu, Bristol-Myers, Cimarex, Deere, Deutsche Bank, Micron, NeoPhotonics, Target, United Continental and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb: A Long Idea for Aggressive Traders Only

Um den gesamten Artikel unter realmoney.thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks.com featured highlights include: BlackRock, Northrop, Progressive, Interpublic Group and Bristol-Myers

Zacks.com featured highlights include: BlackRock, Northrop, Progressive, Interpublic Group and Bristol-Myers...…

Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems

Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems...…

Bristol-Myers Squibbs Opdivo Stumbles In Late-Stage Brain Cancer Study

Bristol-Myers Squibb Co (NYSE: BMY), which is prepping for its purchase of Celgene Corporation (NASDAQ: read more...…

Bristol-Myers Opdivo fails late-stage brain cancer trial

Bristol-Myers Squibb Co said on Thursday its immunotherapy Opdivo failed to meet the main goal of a late-stage trial testing it in…

Bristol Myers Squibb priced 9 international bonds issues in a total amount of USD 19,000m

May 07, 2019 global biopharmaceutical company Bristol Myers Squibb priced 9 international bonds issues in total amount of USD 16,000m.…

Bristol-Myers Squibb Is Selling $19 Billion of Bonds to Buy Celgene

The bond sale is on track to be the biggest so far this year, according to Dealogic data....…

Bristol-Myers Prepares Large Bond Sale To Fund Celgene Purchase

Bristol-Myers Squibb Co. is planning to sell around $20 billion of bonds on Tuesday, seizing on a low-interest rate environment…

Bristol-Myers Squibb And BMS-986036 In NASH: An Update

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Stocks Gets Boost as Analyst Touts Celgene Acquisition

Barclays analyst Geoff Meacham thinks that the companies’ combined drug pipelines make Bristol-Myers a force to watch in the years…

Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Cramer reviews the top activist stories of 2019: eBay, Dollar Tree, Bristol-Myers, Bed Bath & Beyond

"Sometimes, they reach an accommodation with management and it works. Other times they get involved in proxy fights ... and…

2019s top activist stories: eBay, Dollar Tree & more

'Mad Money' host Jim Cramer reviews the best activist stories of this year, including eBay, Dollar Tree, Bristol-Myers and Bed,…

The Zacks Analyst Blog Highlights: FirstEnergy, Synchrony Financial, ExxonMobil, Morgan Stanley and Bristol-Myers

The Zacks Analyst Blog Highlights: FirstEnergy, Synchrony Financial, ExxonMobil, Morgan Stanley and Bristol-Myers...…

Top Research Reports for ExxonMobil, Morgan Stanley & Bristol-Myers

Top Research Reports for ExxonMobil, Morgan Stanley & Bristol-Myers...…

Eliquis Will Continue To Drive Bristol-Myers Squibbs Near Term Earnings Growth

Bristol-Myers Squibb (NYSE:BMY) recently reported its Q1 earnings, and they came in slightly above our estimates, led by margin expansion.…

Bristol-Myers Earnings Call Positive For Celgene Holders

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

3 Reasons Why Growth Investors Shouldnt Overlook Bristol-Myers (BMY)

Bristol-Myers (BMY) is well positioned to outperform the market, as it exhibits above-average growth in financials....…

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Q1 Earnings Beat, Sales Up on Strong Eliquis

Bristol-Myers (BMY) Q1 earnings and sales beat estimates on strong performance of Eliquis and Opdivo....…

Bristol-Myers Squibb Co (BMY) Q1 2019 Earnings Call Transcript

BMY earnings call for the period ending March 31, 2019....…

Bristol-Myers Squibb Posts Solid Q1 Results With the Celgene Acquisition Looming

The big drugmaker beat Wall Street estimates in the first quarter thanks to solid sales growth for its top blockbusters....…

Bristol-Myers Stock Is Rising on Upbeat Earnings Guidance

Bristol-Myers Squibb beat first-quarter expectations by a penny, posting earnings per share of $1.10. And the company is more optimistic…

Bristol-Myers Squibb (BMY) Q1 Earnings and Revenues Top Estimates

Bristol-Myers (BMY) delivered earnings and revenue surprises of 0.92% and 2.09%, respectively, for the quarter ended March 2019. Do the…

US-Pharmakonzern Bristol-Myers Squibb startet stark ins neue Jahr

NEW YORK (dpa-AFX) - Der Pharmakonzern Bristol-Myers Squibb (BMS) (Bristol-Myers Squibb) hat seinen Umsatz zum Jahresbeginn deutlich gesteigert. Vor allem…

The Daily Biotech Pulse: Adverum Gets New CFO, Flexions Osteoarthritis Trial, Bristol-Myers Earnings

Heres a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stocks hit…

US-Pharmakonzern Bristol-Myers Squibb startet stark ins neue Jahr

NEW YORK (dpa-AFX) - Der Pharmakonzern Bristol-Myers Squibb (BMS) hat seinen Umsatz zum Jahresbeginn deutlich…

Bristol-Myers sales beat estimates, driven by its blockbuster blood thinner

Um den gesamten Artikel unter bloom.bg zu lesen, klicken Sie bitte auf die Überschrift...…

Key Drugs Lift Bristol-Myers Results Ahead of Celgene Deal

Bristol-Myers Squibb said its first-quarter profit and revenue rose on stronger demand for its key drugs, as the company looks…

Bristols Opdivo, Eliquis lift results

Bristol-Myers Squibb Co. said its first-quarter profit and revenue rose on stronger demand for its key drugs, as the company…

Bristol-Myers profit slightly tops Wall Street view on blood thinner sales

U.S drugmaker Bristol-Myers Squibb Co, which is set to buy biotechnology company Celgene Corp for $74 billion, posted slightly better-than-expected…

Bristol-Myers Tops Q1 Earnings Estimate After Winning Celgene Takeover Approval

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb und Celgene: Der Fahrplan für die Übernahme

Die Übernahme wird kommen. Doch sollte man mitgehen?...…

Bristol-Myers Squibb Expected to Earn $1.09 a Share

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…